Dehaier Medical Systems Announces Closing of Initial Public Offering on NASDAQ

USA - English

• USA - English

BEIJING, April 22 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM), an emerging leader in the development, assembly, marketing and sale of medical products in China, announced today its initial public offering of 1,500,000 ordinary shares at $8.00 per share. The ordinary shares will begin trading today under the ticker symbol "DHRM" on the Nasdaq Capital Market.

(Logo: http://www.newscom.com/cgi-bin/prnh/20100422/CNTH001LOGO )

Of the 1,500,000 shares sold in the offering, all of the shares were sold by Dehaier Medical Systems.

Anderson & Strudwick, Inc. acted as the lead placement agent for the offering.

This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    A copy of the prospectus relating to the offering may be obtained from:

    Mac Downs, Managing Director
    Anderson & Strudwick, Inc.
    707 East Main Street, 20th Floor
    Richmond, VA  23219
    Phone: +1-804-966-2468
    Email: [email protected]

About Dehaier Medical Systems Ltd.

Dehaier Medical Systems is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare products. The company develops and assembles its own branded products from third party components. The company also distributes products designed and manufactured by other companies including medical devices and respiratory and oxygen homecare products from IMD (Italy), Timesco (UK), ResMed (Australia) and JMS (Japan). Dehaier's technology is based on two patents, five pending patents and proprietary technology. More information may be found at http://www.chinadhr.com .

Information for investors about Dehaier is available at http://www.hawkassociates.com/profile/dhrm.cfm . Investors may contact Julie Marshall or Susan Zhou, Hawk Associates, at (305) 451-1888, e-mail: [email protected] . An online investor kit including press releases, current price quotes, stock charts and other valuable information for investors is available at http://www.hawkassociates.com .

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

    For further information, please contact:

    Hawk Associates
     Julie Marshall or Susan Zhou
     Tel:   +1-305-451-1888
     Email: [email protected]

SOURCE Dehaier Medical Systems Ltd.